Brain Tumor Treatments: Texas
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Texas
Please scroll down to see the matching trials.
  (0.8169)   Brain Tumor Treatments: Texas
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   RSR-13
  (0.7967)   Noteworthy Treatments For Brain Tumors
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Treatments
  (0.7742)   Treatments
  (0.7742)   BORON NEUTRON CAPTURE THERAPY (BNCT)
  (0.7742)   Chemosensitivity Testing
  (0.7742)   Doctor / Hospital Address Book
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   BrainTumor Chat: Dr. Friedman
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Temozolomide Update
  (0.7742)   Untitled Document
  (0.7742)   Noteworthy Treatments For Brain Tumors
  (0.7742)   Brain Tumor Treatments: Gene Therapy

Sorry - There were no pages found that contain that search phrase.



  Showing Treatment 1 to 25 of 122 Next 25 Location Last Updated
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Dallas, TX USA 09/30/2009
Details Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme Houston, TX USA 08/11/2009
Details Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma Houston, TX USA 04/14/2009
Details Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma Houston, TX USA 04/03/2009
Details Phase II study of CDX-110 with radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme Houston, TX USA 04/03/2009
Details Phase III, randomised, parallel Group, multi-centre study in recurrent glioblastoma patients to compare the efficacy of cediranib monotherapy and the combination of cediranib with lomustine to the efficacy of lomustine alone Houston, TX USA 04/03/2009
Details Phase III double blind, placebo controlled study of donepezil in irradiated brain tumor patients Houston, TX USA 04/03/2009
Details Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer Dallas, TX USA 03/15/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Houston, TX USA 01/31/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) San Antonio, TX USA 01/31/2009
Details Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas Houston, TX USA 10/27/2008
Details Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas San Antonio, TX USA 10/27/2008
Details Phase I study of MPC-6827 in combination with carboplatin for recurrent glioblastoma Houston, TX USA 10/27/2008
Details A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme Houston, TX USA 10/27/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma Houston, TX USA 10/09/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer Houston, TX USA 07/24/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer San Antonio, TX USA 07/24/2008
Details Gliogene: An International Brain Tumor Study Houston, TX 07/24/2008
Details Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma Houston, TX USA 05/28/2008
Details Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme Houston, TX USA 05/28/2008
Details Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme Houston , TX 04/27/2008
Details Phase I/II Study of Temozolomide and Intrathecal DepoCyt in Patients with Neoplastic Meningitis Houston, TX USA 04/16/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 04/15/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma San Antonio, TX USA 04/15/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 04/15/2008


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites